Abstract

Although sub-Saharan Africa is the epicentre of sickle cell anaemia globally, until recently, the disease has been widely neglected within the region. During the late 1990s, mortality in children younger than 5 years in sub-Saharan Africa was close to 200 per 1000 livebirths,1 and consequently, an incurable disease such as sickle cell anaemia affecting ten per 1000 children was not a priority. However, with many sub-Saharan African countries going through a period of epidemiological and demographic transition, overall child mortality is declining rapidly and provision of better care for children born with sickle cell anaemia has now become a necessity.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.